Chondrial Therapeutics
-
2013
Company Description
Chondrial Therapeutics LLC was formed to discover and develop orphan drugs for mitochondrial diseases.
Chondrial Therapeutics LLC was formed to discover and develop orphan drugs for mitochondrial diseases. Their proprietary protein replacement platform is initially targeted at Friedreich's ataxia, a disease afflicting more 20,000 people in the US and Europe. Their goal is to restore normal life to individuals with mitochondrial diseases. Hope is on the horizon.
-
Manufacturer:
Science and Engineering -
Formed:
2013 -
Founders:
R. Mark Payne -
Company Website:
-
Company E-mail:
-
Company Address:
150 Monument Road,, Suite 207Bala Cynwyd, PAUnited States -
CEO:
- R. Mark Payne
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits